BIOMAT Database Logo BIOMAT Database Logo

Lofexidine in abrupt methadone withdrawal. 1982

A M Washton, and R B Resnick

UI MeSH Term Description Entries
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

A M Washton, and R B Resnick
Abrupt withdrawal of maintenance methadone.
September 1971, JAMA,
A M Washton, and R B Resnick
Lofexidine and opioid withdrawal.
June 1995, Lancet (London, England),
A M Washton, and R B Resnick
Lofexidine in alcohol withdrawal states.
January 1986, Alcohol and alcoholism (Oxford, Oxfordshire),
A M Washton, and R B Resnick
Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
December 1996, Drug and alcohol dependence,
A M Washton, and R B Resnick
Lofexidine (Lucemyra) for opioid withdrawal.
July 2018, The Medical letter on drugs and therapeutics,
A M Washton, and R B Resnick
Lofexidine blocks acute opiate withdrawal.
April 1982, NIDA research monograph,
A M Washton, and R B Resnick
Abrupt propranolol withdrawal.
April 1977, Archives of internal medicine,
A M Washton, and R B Resnick
Lofexidine, a clonidine analogue effective in opiate withdrawal.
May 1981, Lancet (London, England),
A M Washton, and R B Resnick
Alcohol withdrawal syndromes: clinical management with lofexidine.
January 1985, Alcoholism, clinical and experimental research,
A M Washton, and R B Resnick
Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
May 1998, Drug and alcohol dependence,
Copied contents to your clipboard!